Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Feifer

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancer|November 11, 2011
Androgen deprivation and thromboembolic events in men with prostate cancerBehfar Ehdaie, Coral L Atoria, Amit Gupta, et al.
International Journal of Cardiology|July 23, 2013
Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliationBrian J Potter, Peter Leong-Sit, Susan M Fernandes, et al.
BJU International|March 21, 2013
Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine modelJonathan L Silberstein, Preston C Sprenkle, Daniel Su, et al.
The Journal of Urology|November 16, 2010
Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma casesAndrew Feifer, Caroline Savage, Heidi Rayala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2022
Explainable artificial intelligence to predict the risk of side-specific extraprostatic extension in pre-prostatectomy patientsJethro C C Kwong, Adree Khondker, Christopher Tran, et al.
BJU International|November 17, 2011
Locally advanced prostate cancer: a population-based study of treatment patternsWilliam T Lowrance, Elena B Elkin, David S Yee, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiCGeoffrey Gotto, Darrel E Drachenberg, Joseph Chin, et al.
JMIR Cancer|October 4, 2023
An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development StudyKaylen J Pfisterer, Raima Lohani, Elizabeth Janes, et al.
Communications Medicine|November 3, 2023
A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship careKaren Young, Ting Xiong, Kaylen J Pfisterer, et al.
The Lancet. Oncology|September 4, 2025
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trialTamim Niazi, Fred Saad, Steven Tisseverasinghe, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancer|November 11, 2011
Androgen deprivation and thromboembolic events in men with prostate cancerBehfar Ehdaie, Coral L Atoria, Amit Gupta, et al.
International Journal of Cardiology|July 23, 2013
Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliationBrian J Potter, Peter Leong-Sit, Susan M Fernandes, et al.
BJU International|March 21, 2013
Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine modelJonathan L Silberstein, Preston C Sprenkle, Daniel Su, et al.
The Journal of Urology|November 16, 2010
Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma casesAndrew Feifer, Caroline Savage, Heidi Rayala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2022
Explainable artificial intelligence to predict the risk of side-specific extraprostatic extension in pre-prostatectomy patientsJethro C C Kwong, Adree Khondker, Christopher Tran, et al.
BJU International|November 17, 2011
Locally advanced prostate cancer: a population-based study of treatment patternsWilliam T Lowrance, Elena B Elkin, David S Yee, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiCGeoffrey Gotto, Darrel E Drachenberg, Joseph Chin, et al.
JMIR Cancer|October 4, 2023
An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development StudyKaylen J Pfisterer, Raima Lohani, Elizabeth Janes, et al.
Communications Medicine|November 3, 2023
A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship careKaren Young, Ting Xiong, Kaylen J Pfisterer, et al.
The Lancet. Oncology|September 4, 2025
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trialTamim Niazi, Fred Saad, Steven Tisseverasinghe, et al.
Pageof 4